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Abstract
Exogenous applications of brassinolide (BL) increased the number and quality of microspore-derived embryos (MDEs)
whereas treatments with brassinazole (BrZ), a BL biosynthetic inhibitor, had the opposite effect. At the optimal
concentration (4310
26 M) BrZ decreased both embryo yield and conversion to less than half the value of control
embryos. Metabolic studies revealed that BL levels had profound effects on glutathione and ascorbate metabolism by
altering the amounts of their reduced forms (ASC and GSH) and oxidized forms [dehydroascorbate (DHA), ascorbate
free radicals (AFRs), and GSSG]. Applications of BL switched the glutathione and ascorbate pools towards the oxidized
forms, thereby lowering the ASC/ASC+DHA+AFR and GSH/GSH+GSSG ratios. These changes were ascribed to the
ability of BL to increase the activity of ascorbate peroxidase (APX) and decrease that of glutathione reductase (GR).
This trend was reversed in a BL-depleted environment, effected by BrZ applications. These metabolic alterations were
associated with changes in embryo structure and performance. BL-treated MDEs developed zygotic-like shoot apical
meristems (SAMs) whereas embryos treated with BrZ developed abnormal meristems. In the presence of BrZ, embryos
either lacked a visible SAM, or formed SAMs in which the meristematic cells showed signs of differentiation, such as
vacuolation and storage product accumulation. These abnormalities were accompanied by the lack or misexpression
of three meristem marker genes isolated from Brassica napus (denoted as BnSTM, BnCLV1,a n dBnZLL-1)h o m o l o g o u s
to the Arabidopsis SHOOTMERISTEMLESS (STM), CLAVATA 1 (CLV1), and ZWILLE (ZLL). The expression of BnSTM and
BnCLV1 increased after a few days in cultures in embryos treated with BL whereas an opposite tendency was
observed with applications of BrZ. Compared with control embryos where these two genes exhibited abnormal
localization patterns, BnSTM and BnCLV1 always localized throughout the subapical domains of BL-treated embryos in
a zygotic-like fashion. Expression of both genes was often lost in the SAM of BrZ-treated embryos. The results suggest
that maintenance of cellular BL levels is required to modulate the ascorbate and glutathione redox status during
embryogenesis to ensure proper development of the embryos and formation of functional apical meristems.
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Introduction
The ability of plant cells to regenerate embryos in culture,
ﬁrst reported by Levine (1947), has been extensively exploited
for propagating angiosperm and gymnosperm species (see
Dunstan et al.,1 9 9 5 ; Thorpe and Stasolla, 2001). One way in
which embryos are produced in culture is through gameto-
phytic androgenesis, in which the developmental fate of
Abbreviations: AFR, ascorbate free radical; AFRR, ascorbate free radical reductase; APX, ascorbate peroxidase; ASC, reduced ascorbate; BL, brassinolide; BR,
brassinosteroid; BrZ, brassinazole; CLV1, Clavata 1; DHA, dehydroascorbate; DHAR, dehydroascorbate reductase; GR, glutathione reductase; GSH, reduced
glutathione; GSSG, oxidized glutathione; MDE, microspore-derived embryo; RAM, root apical meristem; SAM, shoot apical meristem; STM, Shootmeristemless; ZLL,
Zwille.
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towards an embryogenic pathway. This process is advanta-
geous in that the endogenous genetic variation can be ﬁxed
with the recovery of double haploid plants after chromosome
doubling by colchicine treatments (Yao et al.,1 9 9 7 ).
Androgenesis has been applied to a variety of species,
including Brassica napus, and successfully implemented in
breeding programmes. Production of Brassica microspore-
derived embryos (MDEs) has been facilitated by several
optimizations of culture and media conditions (Ferrie et al.,
2005; Belmonte et al.,2 0 0 6 ; Stasolla et al.,2 0 0 8 ) and has
become a suitable model system to study embryogenesis.
Through this system, a large number of synchronized
embryos can be produced in a short period of time, thereby
allowing the selection of stage-speciﬁc embryos to be used for
physiological and molecular studies. This is especially
important for studying early embryogeny, as immature
embryos produced in vivo are embedded in the maternal
tissue and difﬁcult to dissect. Comparative studies between in
vivo and in vitro systems are possible due to the similar
morphogenic events underlying the development of B. napus
MDEs and zygotic embryos (Yeung et al.,1 9 9 6 ). In addition,
the genetic information available in Arabidopsis can be used
in Brassica given the high similarities shared between the two
species. Therefore, B. napus MDE culture has been used in
many studies investigating structural, physiological, and
molecular events during embryogenesis (Yeung, 2002;
Boutiler et al., 2005; Belmonte et al.,2 0 0 6 ; Joosen et al.,
2007; Malik et al.,2 0 0 7 ).
Physiological studies have shown that a key regulator of
embryo development is represented by the glutathione and
ascorbate redox status, as deﬁned by the balance between the
respective reduced forms [reduced glutathione (GSH) and
reduced ascorbate (ASC)] and oxidized forms [oxidized
glutathione (GSSG), dehydroascorbate (DHA), and ascorbate
free radicals (AFRs)]. A switch of the redox status towards
a more reduced environment (high GSH/GSH+GSSG and
ASC/ASC+DHA+AFR ratios) is observed during the early
days in culture whereas a more oxidized environment (low
GSH/GSH+GSSG and ASC/ASC+DHA+AFR ratios)
occurs during the late stages of development (Stasolla and
Yeung, 2001; Belmonte et al.,2 0 0 6 ; Belmonte and Stasolla,
2007). Experimental manipulations of these ratios improve
the yield and quality of MDEs (Belmonte et al.,2 0 0 6 ;
Stasolla et al.,2 0 0 8 ). Recent work has shown that the
imposition of an oxidized environment enhances the struc-
ture of B. napus MDEs and favours the formation of
functional shoot apical meristems (SAMs). These improve-
ments would ensure the successful regeneration of the
embryos into vigorous plants (Stasolla et al.,2 0 0 8 ).
Steroids are a group of growth-promoting natural
products ubiquitous to both plants and animals involved in
several aspects of development (reviewed by Bishop and
Koncz, 2002). Plants are able to synthesize a variety of
sterols and steroids, including brassinosteroids (BRs)
(Clouse, 1996). Interest in these compounds emerged from
the pioneering work of Mitchell et al. (1970) showing that
extract of rape pollen containing BRs possessed growth-
promoting properties. Since then, BRs have been associated
with a variety of cellular responses, with elongation and
proliferation being the most characterized. Their applications
in several systems induced cell elongation and proliferation
through auxin- and cytokinin-independent pathways (Adam
and Marquardt, 1986; Mandava, 1988; Azpiroz et al.,1 9 9 8 ).
Additional BR-induced responses include tracheary element
differentiation (Yamamoto et al.,1 9 9 7 ), activation of proton
pumps, growth of pollen tube, leaf bending (Mandava,
1988), resistance to abiotic stress (Brosa, 1999; Clouse,
2001), and induction of ethylene synthesis (Schlagnhaufer
and Arteca, 1991). In recent years the discovery and
characterization of mutants have further established the key
role played by BRs during plant growth and development
(Clouse and Sasse, 1998). Given their emerging role as
phytohormones it is not surprising that they have been
exploited by tissue culturists to stimulate in vitro growth and
morphogenesis. Besides promoting cell division of protoplast
cultures (Nakajima et al.,1 9 9 6 ; Oh and Clouse, 1998),
exogenous applications of brassinolide (BL), the most active
form of BRs, induced adventitious shoot regeneration from
hypocotyl segments of Brassica oleracea (Sasaki, 2002). A
similar beneﬁcial effect was also reported by Pullman et al.
(2003) who observed an improvement in embryogenic tissue
initiation when exogenous BL was added to loblolly pine and
rice cell cultures. A more recent study (Ferrie et al.,2 0 0 5 )
revealed that two forms of BRs, 24-epibrassinolide and BL,
enhanced the yield of MDEs from several Brassica species
possibly by protecting microspores from the imposed
heat stress required for the initiation of the embryogenic
programme.
Besides this speculation, to date there is no clear in-
formation on the requirement for BRs, and BL in particular,
during embryogenesis. One way to gain a better understand-
ing of the function of this phytohormone during embryo
development is to manipulate its endogenous level experi-
mentally and assess embryo yield and quality. This approach
has been rendered possible by the work of Asami et al. (2000)
who, through the screening of BR biosynthesis inhibitors,
identiﬁed brassinazole (BrZ) as the most potent inhibitor.
The speciﬁcity of this compound was further demonstrated in
two independent studies in which BrZ inhibition of second-
ary xylem development in Lepidium sativum and stem
elongation in Arabidopsis were reversed by exogenous
applications of BL (Asami et al.,2 0 0 0 ; Nagata et al.,2 0 0 1 ).
Here BrZ is used to assess the role played by BL during
B. napus microspore-derived embryogenesis. It is proposed
that maintenance of cellular BL levels is required to
modulate the ascorbate and glutathione redox status during
embryogenesis and ensure proper development of the
embryos and formation of functional apical meristems.
Materials and methods
Brassica napus embryo development: BrZ and BL treatments
Growth of B. napus cv Topaz DH4079 plants, isolation of
microspores and induction of MDE development were carried out
2780 | Belmonte et al.exactly as described by Belmonte et al. (2006). BL was obtained
from Wako Pure Chemical Industries, Ltd (Cat # 635-00811),
whereas BrZ was kindly provided by Dr T Asami. Different levels
of the two compounds (BL, 10
 8–10
 5 M; BrZ, 5310
 7 Mt o
4310
 6 M) were applied in the initial medium (day 0) and
maintained in culture throughout the maturation phase exactly as
indicated by Ferrie et al. (2005), unless speciﬁed otherwise. For
conversion frequency tests, control and treated embryos were
harvested at days 15, 20, 25, and 35 to assess the optimal stage for
conversion, that is production of a functional root and shoot,
upon transfer to germination medium. The germination medium
consisted of half-strength MS medium (Murashige and Skoog,
1962) supplemented with 2% sucrose and 0.8% puriﬁed agar pH.
5.8 (Belmonte et al., 2006) and was devoid of BrZ and BL. For
yield experiments the embryos were counted at day 35 (Belmonte
et al., 2006).
Metabolic studies and histological analysis
Measurements of endogenous glutathione and ascorbate, as well as
enzymatic reactions of ascorbate peroxidase (APX), dehydroascor-
bate reductase (DHAR), glutathione reductase (GR), and ascor-
bate free radical reductase (AFRR) were carried out exactly as
reported by Stasolla and Yeung (2001) and Belmonte et al. (2006).
Structural studies during embryo development were performed
following the procedure outlined by Yeung (1999). To assess the
percentage of embryos with abnormal meristems, >150 longitudi-
nal sections were analysed at each time point in each treatment.
The analyses was performed using three independent experiments.
Expression of SAM marker genes
Expression studies of the isolated BnSTM (GU480584), BnCLV1
(GU480586), and BnZLL-1 (EU329719) during MDE development
were conducted by semi-quantitiative RT-PCR. Brieﬂy, total RNA
was extracted during MDE development using a QIAGEN
RNeasy
  Plant mini Kit (Cat. # 74904) and used to generate
cDNA with Invitrogen SuperScript
  II Reverse Transcriptase (Cat.
# 19064-002). For RT-PCR studies the following primers were used:
BnSTM,5 #-TGATGGTCCGATGTGTCCTA-3# and 5#-TGTTC-
TCCTTCCTCTGGTGC-3#; BnCLV1,5 #-TCTCCTTCAACGACC-
TCTCG-3# and 5#-CGAAAGGACTGTGTTATCTTCACCA-3#;
BnZLL-1, AAACTCAAACTTTGCGCCGAGACC-3# and 5#-
ATCATCAATGGCCCTAGGAGGGAG-3#. In order to measure
the relative difference in transcripts levels, the ampliﬁcation was
carried out when the PCR product was accumulating within the
exponential phase. As an internal control, actin (accession number
AF111812) was used (5#;-TAAAGTATCCGATTGAGCATGG-
TAT-3#; and 5#;-GACATTAAAGAGAAGCTTGCCTACG-3#).
The following conditions were used for BnSTM, BnCLV1, and
BnZLL-1 (94  C for 30 s, 55  C for 30 s, 72  C for 1 min, 27
cycles), and for actin (94  C for 30 s, 55  C for 30 s, 72  C for
1 min, 24 cycles). The gels were analysed using an Alphaimager
HP. A sample gel is shown in Supplementary Fig. S1 available at
JXB online.
For RNA in situ hybridization studies the three full-length
cDNAs were cloned into a pGEM Vector the using pGEM-T Easy
Vector System (Promega Cat.# A1360). The cDNA fragments
were ampliﬁed from the vector using T7 and SP6 primers and used
for the preparation of digoxigenin (DIG)-labelled sense and
antisense riboprobes, exactly as described in the DIG Application
Manual (Roche Applied Science). Slide preparation, hybridization
conditions, and colour development were performed using the
method outlined in Belmonte et al. (2006)
Statistical analysis
Tukey’s post-hoc test for multiple variance (Zar, 1999) was used to
compare differences between treatments and control.
Results
Effects of BL and BrZ on embryo yield and conversion
Inclusions of BL in the culture medium increased MDE
yield at any concentration used (Fig. 1A). At the optimal
level (10
 7 M), BL increased the number of embryos
produced >5-fold. Embryo production was signiﬁcantly
reduced by BrZ especially when applied at a concentration
of 4310
 6 M( Fig. 1B). To eliminate the possibility that this
effect was due to the toxicity of the inhibitor rather than to
its ability to repress the synthesis of BL, BL was applied (at
its optimal concentration) in conjunction with BrZ. The
combined applications of these two compounds reversed the
inhibitory effect of BrZ and increased the percentage of
embryo yield to control values (Fig. 1B). External analyses
of the embryos clearly showed that BrZ reduced the length
Fig. 1. Number of MDEs developed in the presence of different
levels of (A) brassinolide (BL) and (B) brassinazole (Brz). Treat-
ments were applied at day 0 (see Materials and methods for
details) and the embryos were counted at day 35. Values are
expressed as percentages relative to control and are means 6SE
of at least three independent experiments. * indicates values that
are statistically signiﬁcantly different (P <0.05) from control. (C)
External morphology of embryos treated as in B.
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(Fig. 1C).
Conversion frequency (formation of visible root and
shoot systems at germination) after treatments with BrZ
and BL was measured in embryos harvested at different
days during development (day 15, 20, 25, and 35). The
conversion frequency of control embryos was highest at day
15 and declined during the following harvesting days (Fig.
2A). Differences between treatments were observed after
day 15, when applications of BL markedly increased the
post-embryonic performance of the MDEs. After day 20,
BL, at any concentration used, more than doubled the
conversion frequency of the embryos compared with control
(Fig. 2A). Due to the limiting amount of BrZ available, the
effect of this inhibitor was tested in embryos harvested at
day 25, when the beneﬁcial effect of BL became apparent.
Embryo conversion decreased with increasing levels of BrZ
(Fig. 2B), and this inhibition was reversed by the combined
inclusion of BL+BrZ.
Effects of BL and BrZ applications on glutathione and
ascorbate metabolism
Ascorbate and glutathione production in plant cells is
tightly linked through the activity of common enzymes
(Fig. 3). The level of cellular GSH in control embryos was
highest at day 15 and it declined during the following days
in culture (Fig. 4A). In these embryos, cellular GSSG was
always very low. Overall, applications of BL increased the
total glutathione pool and this was mainly the result of
increasing levels of the oxidized form GSSG. The highest
levels of GSH were measured in BzR-treated embryos
which were almost depleted of GSSG. When BL was
applied with BrZ, a small but consistent increase in GSSG
was observed (Fig. 4A). Different proﬁles in the glutathione
redox state (GSH/GSH+GSSG ratio) were observed during
MDE development (Fig. 4B). In BrZ-treated embryos this
ratio remained high throughout the culture period whereas
a switch of the glutathione pool towards an oxidized state
was observed in the presence of BL. Intermediate levels of
the GSH/GSH+GSSG ratio were observed for control
embryos and embryos treated with BL+BrZ (Fig. 4B).
The total ascorbate level of control embryos increased
during development, reaching a maximum value at day 25
before declining during the following days (Fig. 5A). Within
this pool ASC was always the predominant form. An
overall enrichment in DHA+AFR was observed in BL-
treated embryos and this contributed to the enlargement of
the total ascorbate pool. An opposite trend was noticed for
embryos cultured with BrZ which, compared with the other
treatments, displayed the lowest total ascorbate level after
day 15. This trend was, however, reverted if BL was added
to BrZ (Fig. 5A). Different patterns in the ascorbate redox
state (ASC/ASC+DHA+AFR ratio) were observed during
MDE development (Fig. 5B). In the presence of BrZ the
ascorbate pool remained in a reduced state throughout the
developmental programme, whereas it switched slowly to-
wards an oxidized state in embryos treated with BL (Fig. 5B).
Intermediate values were observed for control embryos and
embryos cultured with BL+BrZ.
Among the enzymes involved in glutathione and ascor-
bate metabolism (Fig. 3), the activity of GR ﬂuctuated
during development in all treatments (Fig. 6). The highest
activity of this enzyme was measured in the presence of BrZ
after 25 d in culture. Overall BL treatments reduced the
activity of GR. The proﬁles of APX, the enzyme converting
Fig. 2. Percentage of MDE conversion. Embryos were harvested
at day 15, 20, 25, and 35 during development and transferred
onto germination medium. Embryos were developed in the
presence of different levels of (A) brassinolide (BL) and (B)
brassinazole (Brz). Embryos cultured with BrZ were plated onto
germination medium at day 25. Values are means 6SE of at least
three independent experiments.* indicates values that are statisti-
cally signiﬁcantly different (P <0.05) from control at the same day
in culture.
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change throughout development regardless of the treat-
ments. The lowest activity of this enzyme was observed in
BrZ-treated embryos at all days in culture whereas the
highest activity values were measured in embryos treated
with BL. No signiﬁcant differences in activity proﬁles were
observed for DHAR among treatments. The activity of the
other ascorbate recycling enzyme, AFRR, slowly declined
during maturation in control embryos, as well as in
embryos treated with BrZ and BL+BRZ. At the end of the
developmental programme the highest activities of this
enzyme were measured in embryos treated with different
levels of BL (Fig. 6).
Structural analyses of MDEs treated with BL or BrZ
Major structural differences among treatments were ob-
served within the apical poles of the embryos: the SAM and
the root apical meristem (RAM). At the end of the culture
period the SAM of control embryos was composed of a few
layers of cytoplasmic cells subtended by elongated and
vacuolated cells (Fig. 7A). Formation of intercellular
spaces, which disrupted the integrity of the subapical cells,
was observed in the majority of the SAMs analysed.
Compared with their control counterparts, the apical poles
of BL-treated embryos were more organized; they were
mainly dome-shaped and composed of a larger number of
cytoplasmic cells (Fig. 7B). Two extreme major structural
abnormalities were observed in the SAMs of BrZ-treated
embryos. In ;70% of the abnormal embryos the apical
poles lacked a visible SAM (Fig. 7C) whereas in other cases
(;30%) SAMs were present but were devoid of the
characteristic cytoplasmic cells occupying the apical layers.
Pronounced vacuolation and accumulation of storage
products were observed within these SAMs (Fig. 7D). The
RAM of control embryos was always very deﬁned, with
a group of large cells subtending the procambial region
(Fig. 7E). Such an arrangement, also visible in BL-treated
embryos (data not shown), was lost in embryos cultured
with BrZ (Fig. 7F). Minor structural alterations as a result
of BrZ treatments were also observed in the cotyledons.
Compared with control (Fig. 7G), the cotyledons of BrZ-
treated embryos displayed a corrugated epidermal layer
(Fig. 7H) and were often characterized by small cellular
protrusions (Fig. 7I). Cotyledons of embryos cultured in the
presence of BL were similar to those of control embryos
(data not shown).
The effect of BrZ on SAM development was further
investigated by applying the inhibitor at speciﬁc days in
culture throughout the developmental programme (Table 1)
or during speciﬁc windows of time in the initial phases of
development (Table 2). The negative effects of BrZ on SAM
development only occurred if the inhibitor was included in
the medium within the ﬁrst 15 d in culture (Table 1) and the
most deleterious results were observed if BrZ was applied
between day 10 and day 15 (Table 2).
Expression and localization patterns of SAM
marker genes
The relative expression of the three SAM marker genes
BnSTM, BnCLV1, and BnZLL-1 was measured during
MDE development (Fig. 8). To facilitate the interpretation
of the data, the expression of the genes was based on
comparisons with transcript levels at day 5 (set at 1) for
each treatment. This was possible since no statistically
signiﬁcant differences were observed in the transcript levels
of embryos collected at day 5 regardless of the treatment.
The expression of BnSTM increased during development in
control embryos (Fig. 8). A similar, but more pronounced
trend was observed in the presence of BL (10
 7 M, which
was the optimal concentration for improving embryogene-
sis, Fig. 1a). Applications of BrZ repressed the expression of
this gene; this repression was relieved in BL+BrZ-treated
embryos. The expression proﬁles of BnCLV1 in the different
treatments mimicked those observed for BnSTM. The
expression of this gene increased in the presence of BL
whereas it decreased when BrZ was applied to the culture
medium. This inhibitory effect was reversed when BL was
added to the inhibitor (BL+BrZ). No major differences in
expression pattern among treatments were observed for
BnZLL-1 (Fig. 8).
In globular-stage control embryos, BnSTM was mainly
localized in the apical pole (Fig. 9A1) although a delocalized
Fig. 3. Simpliﬁed diagram showing the ascorbate–glutathione system. ASC, reduced ascorbate; AFR, ascorbate free radicals; DHA,
dehydroascorbate; GSH, reduced glutathione; GSSG, oxidized glutathione; H2O, water; H2O2, hydrogen peroxide; NADP
+, nicotinamide
adenine dinucleotide phosphate oxidized form; NADPH, nicotinamide adenine dinucleotide phosphate reduced form; AFRR, ascorbate
free radical reductase; APX, ascorbate peroxidase; DHAR, dehydroascorbate reductase; GR, glutathione reductase.
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early cotyledonary embryos (Fig. 9A3). In fully developed
control embryos BnSTM transcripts were present in the
subapical layers of the SAM, although some pockets of cells
often remained unstained (Fig. 9A4). In the presence of
BrZ, BnSTM was still localized in the apical pole of
globular embryos, but conﬁned to a smaller pocket of cells
(Fig. 9A5). Upon further development a very faint signal
was visible in the apical pole of middle cotyledonary
embryos (Fig. 9A6) At the end of the culture period, BrZ-
treated embryos lacking a SAM did not stain for BnSTM
(Fig. 9A7), whereas in those forming abnormal SAMs only
a few cells retained its expression (Fig. 9A8). In BL-treated
embryos BnSTM signal was very strong and always re-
stricted to the subapical cells in the central domain of the
SAM throughout development (Fig. 9A9–11). This localiza-
tion pattern coincided with that observed in zygotic
embryos (data not shown). No signal was detected in
sections hybridized with a sense riboprobe (Fig. 9A12).
In globular-stage control embryos, expression of BnCLV1
was ﬁrst localized below the third layer of cells (Fig. 9B1),
before extending to the upper subapical layers in early
Fig. 4. (A) Endogenous levels of reduced (GSH) and oxidized (GSSG) glutathione in MDEs cultured in the presence of brassinolide (BL)
and/or brassinazole (BrZ). Embryos were harvested on different days during development and processed for analyses. (B) Glutathione
redox state expressed as the ratio between GSH and total glutathione (GSH+GSSG) of embryos treated as in A. Values are means 6SE
of at least three independent experiments.
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the end of the culture period the signal was conﬁned in
a few subapical cells within the SAM (Fig. 9B4). As for the
control, BnCLV1 expression was observed in the subapical
cells of BrZ-treated globular embryos (Fig. 9B5). A very
faint signal was also retained in early cotyledonary embryos
(Fig. 9B6). At the end of the culture period BnCLV1
expression occupied the central domain of a few embryos
(<10%) (Fig. 9B7). No signal was observed in the remaining
embryos (Fig. 9B8). BL treatments extended BnCLV1
expression to the second layer of cells of globular embryos
(Fig. 9B9) and to the whole subapical region of the SAM in
early cotyledonary embryos (Fig. 9B10). A very strong
signal was visible throughout the meristematic region of
middle (Fig. 9B11) and late (Fig. 9B12) cotyledonary
embryos. This localization pattern mimicked that of zygotic
embryos (data not shown). The expression domain of
embryos treated with BL+BrZ was similar to that described
for control embryos, whereas no signal was detected when
a sense probe was used (data not shown).
BnZLL was mainly localized within the procambial and
subapical cells of control embryos at the globular stage of
Fig. 5. (A) Endogenous levels of reduced ascorbate (ASC) and its oxidized forms: ascorbate free radicals (AFR) and dehydroascorbate
(DHA) in MDEs cultured in the presence of brassinolide (BL) and/or brassinazole (BrZ). Embryos were harvested at different days during
development and processed for analyses. (B) Ascorbate redox state expressed as the ratio between ASC and total ascorbate
(ASC+AFR+DHA) of embryos treated as in A. Values are means 6SE of at least three independent experiments
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retained mainly in the vascular tissue of middle (Fig. 9C2)
and late (Fig. 9C3) cotyledonary embryos. In the latter,
a faint signal, often extended to the base of the cotyledons,
was present in the subapical cells of the SAM (Fig. 9C3). A
similar expression pattern was also observed in embryos
treated with BL+BrZ (data not shown). In BrZ-treated
embryos, BnZLL expression included the procambial do-
main of globular embryos (Fig. 9C4) and the vascular cells
of middle cotyledonary embryos (Fig. 9C5). At the end of
the culture period no expression was detected within the
SAM (Fig. 9C6). The localization pattern of BnZLL in
developing BL-treated embryos (Fig. 9C7–9) was similar to
that described for their control counterpart. However,
similar to zygotic embryos (data not shown), the expression
of this gene was always observed in a pocket of meriste-
matic cells occupying the central domain of the SAM and
never in lateral regions of the apical pole (Fig. 9C8, 9). No
signal was detected using a sense probe (Fig. 9C10).
Discussion
BL is required for MDE yield, quality, and conversion
In order to evaluate the role played by BRs during
embryogenesis B. napus MDEs were cultured in an environ-
ment enriched or depleted of BL. Brassica napus MDE
development is greatly affected by BL, with high levels
Fig. 6. Activities of the enzymes involved in glutathione and ascorbate metabolism. GR, glutathione reductase; APX, ascorbate
peroxidase; DHAR, dehydroascorbate reductase; AFRR, ascorbate free radical reductase. Embryos were treated with brassinolide (BL)
and/or brassinazole (BrZ) and harvested at different days during development for enzymatic activity. GR, 1 unit¼1 nmol GSH oxidized
mg
 1 protein min
 1; APX. 1 unit¼1 nmol ASC oxidized mg
 1 protein min
 1; AFRR, 1 unit¼1 nmol NADH oxidized mg
 1 protein min
 1;
DHAR, 1 unit¼1 nmol ASC reduced mg
 1 protein min
 1. Values are means 6SE of at least three independent experiments.
2786 | Belmonte et al.promoting embryo formation and conversion, and low
levels, generated by BrZ applications, repressing both pro-
cesses (Figs 1, 2). This inhibitor, the speciﬁcity of which was
demonstrated by the reversion tests, that is BL+BrZ
applications (Figs 1, 2), and other studies (Nagata et al.,
2001), is a triazole derivative able to reduce the supply of
Table 1. Effect of brassinazole (Brz) on the percentage of Brassica napus microspore-derived embryos lacking a visible shoot apical
meristem (SAM) (see Fig. 7C) or with extensive SAM abnormalities (lack of cytoplasmic cells, formation of vacuoles with storage product
accumulation in apical and subapical cells, as well as large intercellular spaces) (see Fig. 7D)
Cultures were treated on the days indicated with brassinazole (BrZ) alone or in conjunction with brassinolide (BL) and observed at day 35 after
being ﬁxed and sectioned (see Materials and methods for details). All data are means 6SE.
Treatments % Embryos with missing or abnormal SAM
Day of application
0 5 10 15 20 25
Control 12611 0 631 3 611 0 661 2 631 0 63
BrZ (4310
 6 M) 78678 6 616 69673 8 612 15648 62
BrZ (4310
 6 M) + BL (10
 7 M) 10636 621 0 635 628 614 62
Fig. 7. Effects of different treatments on MDE structure during development. (A) Fully developed shoot apical meristems (SAMs) of
control embryos were characterized by cytoplasmic apical cells. Small intercellular spaces (arrows) were often observed in these
meristems. (B) The structure of the SAM was much more organized in embryos treated with brassinolide. A larger number of cytoplasmic
cells formed the dome-shaped pole. No intercellular spaces were visible in these meristems. (C, D) Abnormal shoot meristems were
observed in brassinazole-treated embryos. Abnormalities included (C) the absence of a visible SAM within the expanded cotyledons (*) or
(D) poorly organized SAMs characterized by highly vacuolated cells accumulating storage products (arrowheads) and large intercellular
spaces (arrows) disrupting the overall architecture of the apical pole. (E) Both control and BL-treated embryos formed normal root apical
meristems (RAMs) characterized by well-deﬁned cells (arrows) subtending the procambium (*). (F) In embryos treated with brassinazole
(BrZ) these cells were absent. (G) In control and brassinolide-treated embryos cross-sections through expanded cotyledons revealed
a normal cellular organization. (H, I) In embryos treated with brassinazole (H) the epidermal layer of the cotyledons was corrugated and
the subapical cells were often separated by intercellular spaces (*). (I) In several instances clusters of cells (arrows) protruded from the
epidermal layer.
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the oxidation of cathasterone to teasterone (Asami et al.,
2000). Previous tissue culture studies (Pullman et al., 2003;
Ferrie et al., 2005) documented the beneﬁcial effects of BL
during embryogenesis although its mode of action remains
elusive. A possible role for this phytohormone was pro-
posed by Ferrie et al. (2005) who speculated that BL
protects B. napus MDEs from the initial heat shock
treatment applied at the beginning of the culture period to
re-route the gametophytic pathway of the microspores
towards an embryogenic fate. This notion is very plausible
as BRs increased thermotolerance of tomato and B. napus
seedlings (Dhaubhadel et al., 1999), as well as drought
tolerance and cold stress in A. thaliana (Kagale et al., 2007).
The BR protective role was exercised through the activation
of both structural (heat shock proteins) and regulatory
(transcription factors) elements (Kagale et al., 2007). As an
extension of these ﬁndings the present study suggests that
maintenance of cellular BL during early embryogeny is
needed to induce speciﬁc changes in ascorbate and glutathi-
one metabolism required for proper embryo development
and apical meristem formation.
BL enhancement of embryo development correlates
with alterations in glutathione and ascorbate
metabolism
Besides participating in defence reactions against oxidative
stress, the glutathione/ascorbate redox systems are key
regulators of embryogenesis. Speciﬁc ﬂuctuations in the
balance between reduced (ASC and GSH) and oxidized
(DHA+AFR and GSSG) forms accompany embryo de-
velopment in vivo (Arrigoni et al., 1992; Belmonte et al.,
2005). Total ascorbate and glutathione pools are generally
high in immature seeds, to support proliferation of the
growing embryo, before declining steadily during the late
phases of seed maturation. Most importantly, as the
embryo develops, both pools are depleted of their reduced
forms (GSH and ASC) and enriched in their oxidized forms
(GSSG and DHA+AFR) (Arrigoni et al., 1992; Belmonte
et al., 2005). These metabolic ﬂuctuations, resulting in low
GSH/GSH+GSSG and ASC/ASC+DHA+AFR ratios, rep-
resent a switch controlling proper histodifferentiation and
development. Exempliﬁcation of this notion comes from in
vitro experiments where the imposition of an oxidized
environment improves the number and quality of embryos
in both gymnosperm and angiosperm species (Belmonte
et al., 2005; Belmonte and Stasolla, 2007). In spruce (Picea
glauca) an imposed oxidized environment almost doubled
the number of somatic embryos and their post-embryonic
performance (Belmonte et al., 2005). A more pronounced
response was observed in B. napus MDEs when the GSH/
GSH+GSSG ratio was experimentally lowered to values
close to 0.6 using a biosynthetic inhibitor of GSH. Under
this favourable environment the conversion frequency of
the embryos almost tripled (Belmonte and Stasolla, 2007).
The beneﬁcial effects of BL on embryo yield and quality
might be due its ability to switch the glutathione and
ascorbate pool towards an oxidized state. Compared with
control embryos the endogenous level of GSSG increased in
BL treatments (Fig. 4A), possibly due to the lower activity
of GR measured in these embryos (Fig. 6). The activity of
this enzyme which decreased during embryo development in
vivo (Belmonte et al., 2005) catalyses the reduction of GSSG
to GSH (Fig. 3). Increasing levels of GSSG in BL-treated
embryos switched the glutathione pool towards an oxidized
state (low GSH/GSH+GSSG) to values close to 0.6 (Fig.
4B). These values are similar to those observed in zygotic
embryos, and almost identical to those of MDEs in which
the glutathione pool was experimentally shifted towards an
oxidized state to improve embryo conversion (Fig. 1 in
Stasolla et al., 2008). In the presence of a depleted BL
environment, effected by BrZ applications, the glutathione
pool is maintained in a reduced state, which is unfavourable
to embryo development and conversion (Figs 1, 2; Belmonte
et al., 2005). However, if in BrZ-treated embryos the
glutathione pool is forcibly switched towards a more
oxidized state [by inclusions of buthionine sulphoximine
(0.1 M), a GSH inhibitor able to lower the GSH/
GSSG+GSH ratio in MDEs (Stasolla et al., 2008)] both
embryo number and conversion frequency increased to
almost control values (data not shown). This observation
conﬁrms the notion that high levels of cellular BL favour
embryogenesis through the imposition of an oxidized
environment.
Similar metabolic changes to those described for glutathi-
one were also measured for ascorbate. Inclusion of BL in
Table 2. Effect of brassinazole (Brz) on the percentage of Brassica napus microspore-derived embryos lacking a visible shoot apical
meristem (SAM) (see Fig. 7C) or with extensive SAM abnormalities (lack of cytoplasmic cells, formation of vacuoles with storage product
accumulation in apical and subapical cells, as well as large intercellular spaces) see Fig. 7D)
Cultures were treated at the days indicated with brassinazole (BrZ) alone or in conjunction with brassinolide (BL) and observed at day 35 after
being ﬁxed and sectioned (see Materials and methods for details). All data are means 6SE.
Treatments % Embryos with missing or abnormal SAM
Day of application
0–5 5–10 10–15 15–20
Control 13639 621 1 641 3 66
BrZ (4310
 6 M) 34663 7 676 8 662 7 65
BrZ (4310
 6 M) + BL (10
 7 M) 15641 2 639 638 62
2788 | Belmonte et al.the culture medium increased the production of DHA and
AFR, thereby switching the redox state towards an oxidized
environment. An opposite trend was observed when BL was
experimentally depleted by BrZ inclusion (Fig. 5). These
metabolic ﬂuctuations can be explained by the activity of
APX, the recycling enzyme converting ASC to AFR (Fig.
3), which was high in BL-treated embryos and low in the
other treatments, especially in the presence of BrZ (Fig. 6).
Besides reducing ASC, thereby lowering the ASC/ASC+D-
HA+AFR ratio, higher APX activity is required in de-
toxiﬁcation processes (by decreasing the level of H2O2
generated during active cellular proliferation), and in the
regulation of cell wall plasticity (by reducing the endoge-
nous H2O2 utilized by peroxidases in cross-linking cell wall
polymers) (De Gara et al., 1996). Maintenance of cell wall
plasticity was shown to be critical for proper SAM function
in vitro (Stasolla and Yeung, 2007). Another important
difference in ascorbate metabolism among treatments is the
increased level of AFRR, the ASC-recycling enzyme, which
at the end of the developmental period is highest in BL-
Fig. 8. Semi-quantitative RT-PCR analysis of three SAM marker genes isolated from Brassica napus and designated as BnSTM
(SHOOTMERISTEMLESS), BnCLV1 (CLAVATA 1), and BnZLL-1 (ZWILLE). The expression level of these genes was measured in control
embryos and embryos treated with brassinolide (BL) and/or brassinazole (BrZ) on different days in culture. The relative expression is
based on comparisons with transcript levels of day 5 embryos, which are set at 1. The values represent the average of at least three
independent experiments. Asterisks above each bar indicate values which are signiﬁcantly different from control values (P <0.05) at the
same sampling time.
Effects of brassinolide on Brassica napus embryogenesis in vitro | 2789Fig. 9. RNA in situ hybridization studies of BnSTM (A), BnCLV1 (B), and BnZLL-1 (C). Two BnSTM localization patterns were observed in
globular-stage control embryos. BnSTM was either localized in the subapical region of the embryos (A1) or delocalized within two distinct
areas of the apical pole (A2). This latter pattern was often retained in early cotyledonary embryos (A3). In fully developed embryos BnSTM
expression was observed in almost all the subapical cells of the SAM, although pockets of cells (arrows) often remained unstained (A4). In
the presence of brassinazole only a few cells in late globular embryos expressed BnSTM (A5). A faint apical staining was retained in early
cotyledonary embryos (A6) but it was almost completely lost in fully developed embryos characterized by the absence of a visible SAM
(A7) or in an embryo with poorly organized SAMs (A8). In the presence of brassinolide the localization pattern of BnSTM was always
2790 | Belmonte et al.treated embryos and lowest in the BrZ-treated counterparts.
The high level of this enzyme in the presence of BL might
represent a strategy for generating ASC from the oxidized
forms (which are also present at high levels in BL-treated
embryos) at the onset of germination, prior to the
reactivation of the ASC de novo biosynthetic pathway. This
recycling activity during the initial phases of post-embry-
onic growth was observed both in vivo (De Gara et al.,
1997) and in vitro (Stasolla and Yeung, 2001) where it is
required to provide ASC quickly in support of tissue growth
and meristem reactivation (Stasolla and Yeung, 2006). The
inability to recycle ASC promptly at germination may be
one of the causes responsible for the low conversion
frequency observed in the presence of BrZ. This notion is
in line with other studies showing that an experimental
reduction in ASC production at the onset of germination
compromises the reactivation of the meristems (Stasolla and
Yeung, 2006).
The BL-induced changes in ascorbate and glutathione
metabolism would also explain the structural differences of
the apical meristems observed among treatments. Previous
studies (Belmonte et al., 2005; Belmonte and Stasolla, 2007;
Stasolla et al.,2 0 0 8 ) revealed that the beneﬁcial effect of an
imposed oxidized environment during embryogenesis is
mainly due to structural improvements of the apical
meristems. The architecture of the SAM in BL-treated
embryos closely resembles that of SAMs observed in MDEs
cultured under a low GSH/GSH+GSSG ratio (compare
Fig. 7B in this study with Fig. 2F in Stasolla et al., 2008).
Similarly, the abnormal apical poles produced in a BL-
depleted environment share striking features with those of
MDEs cultured in a highly reduced environment (MB and
CS, unpublished results). These abnormalities, which in-
clude the absence of a visible SAM (Fig. 7C), or SAMs in
which the meristematic cells start differentiating, as revealed
by the formation of vacuoles and accumulation of storage
products (Fig. 7D), might contribute to the poor conversion
frequency observed in BrZ-treated embryos. The additional
alterations in RAM structure (Fig. 7F), as well as growth
morphology (Fig. 1C) and cellular organization (Fig. 7H,I )
in these embryos further support the requirement for high
BL levels for proper tissue patterning. This idea is in
agreement with the work of Jang et al. (2000) who revealed
severe defects in embryonic patterning and meristem pro-
gramming in Arabidopsis fackel mutants showing abnormal
sterol composition and lowered BR levels. Abnormal cell
pattering during root meristem formation was also observed
in plants with a mutated BIM1 gene, which is involved in
BR signalling (Chandler et al. 2009).
BL requirement for proper SAM formation is speciﬁc to
the early embyogenic phase, especially between days 10 and
15 (Tables 1, 2), corresponding to the late globular–heart
stage of development. This observation conﬁrms the notion
proposed by Ramesar-Fortner and Yeung (2006) that the
fate of the meristematic cells is not determined, but rather
inﬂuenced by the physiological conditions of embryonic
environment. This inﬂuence can be exercised only within
a short window of time (prior to day 15 in the present
system), after which the fate of the meristematic cells becomes
more determined and their identity cannot be altered. The
negative effect of BrZ on SAM development is attenuated
signiﬁcantly if the inhibitor is applied after day 15 (Table 2).
The BL level affects the expression of SAM
marker genes
The requirement of BL for SAM formation was further
investigated by measuring expression levels and localization
patterns of three SAM marker genes isolated from B. napus
and homologous to Arabidopsis genes involved in apical
speciﬁc to the central subapical region of globular embryos, which always exhibited a very strong signal (A9). This pattern persisted in
early cotyledonary (A10) and fully developed (A11) embryos, where a very strong BnSTM signal was observed throughout the subapical
region of the SAM. No staining was detected when sense RNA was used (A12). In control embryos the expression of BnCLV1 was
observed in globular embryos, where it was localized below the third layers of cells of the embryo proper (B1). In early cotyledonary (B2)
and cotyledonary (B3) embryos the expression of this gene extended to the second layer of cells of the SAM, and remained localized to
the central region of the apical pole. At the completion of the developmental programme BnCVL1 signal was observed in the subapical
domain of the SAM, although not in all cells (B4). Brassinazole-treated globular embryos exhibited a control-like localization pattern (B5).
However, the signal was attenuated in early cotyledonary embryos (B6). At the completion of the developmental programme the
expression pattern of this gene was not consistent among embryos. A visible, but faint signal was still retained in a few embryos (<10%)
(B7), whereas it was almost completely lost in the others (B8). In globular embryos treated with brassinazole BnCLV1 expression was
observed in the apical domain, including the second layer of cells (B9). During the subsequent phases of development, i.e. early
cotyledonary (B10), middle cotyledonary (B11), and late cotyledonary (B12), a very strong signal was observed throughout the subapical
region of the SAM, and included cells of deeper layers. In globular-stage control embryos the expression of BnZLL was mainly localized
in the procambial cells and apical pole (C1). In early cotyledonary embryos a very faint signal was also localized in the subapical cells of
the shoot apical meristem (C2). This localization pattern was retained in fully developed control embryos, although the localization of this
gene within the apical pole was more delocalized and extended to cells at the base of the cotyledon (arrow) (C3). As for control, in
globular BrZ-treated embryos BnZLL transcripts were localized within the procambial region and apical pole (C4). In early cotyledonary
(C5) and late cotyledonary (C6) embryos no signal was detected in the cells of the apical meristem. Although the expression pattern of
globular BL-treated embryos was similar to that of control (C7), BnZLL expression in the presence of BL was localized to a cluster of cells
occupying the central domain of the apical meristem in both early (C8) and late (C9) cotyledonary embryos. No signal was observed using
a sense probe (C10).
Effects of brassinolide on Brassica napus embryogenesis in vitro | 2791meristem development and maintenance. Availability of BL
affects the expression of both BnSTM and BnCLV1. High
BL levels increased the transcripts of both genes after day 5,
while low levels had an opposite effect (Fig. 8). In
Arabidopsis, expression of STM is restricted to the SAM,
where it is required to maintain the meristematic cells in an
undifferentiated state (Long et al., 1996). Genetic studies
revealed that mutations in the stm alleles compromise the
formation of functional SAMs (Endrizzi et al., 1996). The
delocalized expression of this gene observed during de-
velopment of SAM in control embryos is a clear indication
that culture conditions are not optimal for proper meristem
formation. Pockets of cells within the apical pole of control
embryos not expressing BnSTM (Fig. 9A4) might lack the
‘meristematic identity’ conferred by this gene (Long et al.,
1996). This would compromise their reactivation at the
onset of germination. In BL-treated embryos BnSTM
expression is extended throughout the apical pole of
developing embryos (Fig. 9A10, 11), denoting enhanced
SAM functionality and meristem fate acquisition. These
zygotic-like conditions are not met in embryos depleted of
BL where the BnSTM signal is always weak and in some
instances completely lost (Fig. 9A7, 8).
Compared with their control counterparts, BnCLV1
expression was extended in BL-treated embryos from the
early stages of development and encompassed the subapical
domain of the SAM (Fig. 9B). In Arabidopsis, CLV1, which
encodes a putative receptor kinase, is also expressed in the
subapical cells of SAM (in a pattern similar to that
observed in the present study) where together with
WUSCHEL it is involved in feedback loop mechanisms
maintaining a central reservoir of stem cells. Misexpression
of this gene negatively affects the architecture of SAM and
results in the production of an abnormal number of lateral
organs (reviewed by Carles and Fletcher, 2003). The
restricted localization pattern of this gene in BrZ-treated
developing embryos (Fig. 9B5–7), as well as the absence
of a clear signal in many mature embryos (Fig. 9B8),
further supports the role of BL for inducing proper SAM
formation.
The expression pattern of BnZLL-1 was conﬁned to the
vascular tissue and to a lesser extent to the apical pole of
the developing MDEs (Fig. 9C), as also observed for the
Arabidopsis AtZLL (Long, 1996). The role of this gene in
Arabidopsis is to maintain an undifferentiated group of cells
in the SAM during late embryogenesis, possibly by specify-
ing proper STM expression (Moussian et al., 1998). Mature
zll embryos have disrupted SAMs in which the stem cells
differentiate and fail to generate new organs during post-
embryonic growth (Moussian et al., 1998). Although no
differences in BnZLL-1 transcript levels were observed
among treatments (Fig. 8), the expression of this gene was
always localized to a subapical pocket of central cells in
developing BL-treated MDEs (Fig. 9C8, 9) whereas it was
delocalized in their control counterparts (Fig. 9C3), and
completely lost in embryos cultured with BrZ (Fig. 9C6).
The absence of BnZLL-1 expression following BrZ treat-
ments indicates that the molecular mechanisms required for
the establishment of a functional SAM are compromised in
an environment depleted of BL.
In conclusion, the present data indicate that BL plays
a key role during B. napus microspore-derived embryogen-
esis where it improves embryo yield and quality. High levels
of cellular BL affect both glutathione and ascorbate pools
by increasing the contributions of the oxidized forms. The
imposed oxidized environment favours normal embryo
development and apical meristem formation possibly
through the proper expression and localization of meristem
genes. All these events are compromised in a BL-depleted
environment characterized by a reduced redox state, abnor-
mal meristem development, and poor post-embryonic
performance.
Supplementary data
Supplementary data are available at JXB online.
Figure S1. Sample of semi-quantitative RT-PCR of
BnSTM, BnCLV1, and BnZLL-1 in developing Brassica
napus microspore-derived embryos (MDEs) cultured in the
presence of brassinolide (BL) and/or brassinazole (Brz). C,
control or untreated MDEs.
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